Table 1.
Examples of plant-derived pharmaceutical proteins produced via agroinfiltration.
Plant Host | Pharmaceutical Target | Development Stage | References |
---|---|---|---|
N. benthamiana | Influenza A H5N1 HA VLP vaccine | Phase I/II clinical trial | [39,40] |
N. benthamiana | Influenza A H1N1 HA VLP vaccine | Phase I | [41] |
N. benthamiana | Ebola immune-complex vaccine | Preclinical | [29] |
N. benthamiana | HBcAg non-enveloped VLP vaccine | Preclinical | [20] |
N. benthamiana | HBsAg enveloped VLP vaccine | Preclinical | [4] |
N. benthamiana | HIV-1 Pr55gag vaccine | Preclinical | [4] |
N. benthamiana | WNV prM/M and E vaccine | Preclinical | [4,12] |
N. benthamiana, Lettuce | Ebola therapeutics based on mAb | Preclinical | [21,28,34,42] |
N. benthamiana, Lettuce | Norovirus NVCP VLP vaccine | Preclinical | [18,20,34] |
N. benthamiana, Lettuce | WNV therapeutics based on mAb | Preclinical | [6,34] |
N. benthamiana, Lettuce | WNV DIII vaccine | Preclinical | [12,34] |
HA: hemagglutinin; VLP: virus-like particle; HBcAg: hepatitis B core antigen; HBsAg: hepatitis B surface antigen; HIV: human immunodeficiency retrovirus; Pr55gag: major core protein Gag precursor; WNV: West Nile virus; PreM/M: premembrane and membrane protein; E: envelope protein; mAb: monoclonal antibody; NVCP: Norwalk virus capsid protein; DIII: domain III of envelope protein.